These findings are supported by a similar study that found that administration of the PARP1 inhibitor olaparib induced cell death in osteosarcoma cell lines U2-OS, Saos-2, MG-63, and KHOS/NP [76]. The gene discussed is PARP1; the disease is osteosarcoma.